Healthcare - Press Releases

LONDON, Feb. 4, 2025 /PRNewswire/ --The leveraged finance and private equity communities came together on 29 January 2025 for the inaugural Leveraged Finance Fights Melanoma (LFFM) London benefit and cocktail party at The National Gallery. Building on the success of the flagship event in New York City, the London benefit for the Melanoma Research Alliance(MRA) marked a significant milestone in expanding the LFFM franchise into an international platform, with over 600 attendees and raising GBP1.4 million to support MRA's investments in UK-based scientists pursuing high impact, lifesaving melanoma research.

LONDON, Feb. 4, 2025 /PRNewswire/ --The leveraged finance and private equity communities came together on 29 January 2025 for the inaugural Leveraged Finance Fights Melanoma (LFFM) London benefit and cocktail party at The National Gallery. Building on the success of the flagship event in New York City, the London benefit for the Melanoma Research Alliance(MRA) marked a significant milestone in expanding the LFFM franchise into an international platform, with over 600 attendees and raising GBP1.4 million to support MRA's investments in UK-based scientists pursuing high impact, lifesaving melanoma research.

GOUSTRANVILLE, France, 4 fvrier 2025 /PRNewswire/ -- L'cole nationale vtrinaire d'Alfort (EnvA) est fire d'annoncer le lancement officiel des activits du Centre Hospitalier Universitaire Vtrinaire quin (Chuv-Eq), sur le site du Campus International du Cheval, en Normandie. Ce nouveau centre constitue une tape majeure dans le dveloppement des soins, la formation et la recherche en sant quine.

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The globalbiologics contract development and manufacturing organization (CDMO) marketsize is estimated to grow by USD 16.32 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 13.7% during the forecast period. Availability of cost-efficient resources in emerging marketsis driving market growth,with a trend towardsadvent of big data. However,capacity utilization and constraints poses a challenge. Key market players include 3P Biopharmaceuticals, AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals, Catalent Inc., Evonik Industries AG, FUJIFILM Corp., Grifols SA, J RETTENMAIER and SOHNE GmbH and Co KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Electronics Co. Ltd., Shenzhen Hepalink Pharmaceutical Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc..

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global snus marketsize is estimated to grow by USD 1.197 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of about10.7% during the forecast period. Availability of flavored snusis driving market growth,with a trend towardschanging consumption trends in global snus market. However,negative health effects of snus consumption poses a challenge. Key market players include Altria Group Inc., Another Snus Factory Stockholm AB, British American Tobacco Plc, Dholakia Tobacco Pvt. Ltd., Empire of Snus, GN Tobacco Sweden AB, Harsh International, Imperial Brands Plc, Japan Tobacco Inc., Philip Morris International Inc., Swisher International Inc., TIGERSNUSORGANIC SNUS TOBACCO, Turning Point Brands Inc., and Wilsons and Co. Sharrow Ltd..

Plant-Based Protein Brand,VEGA, Launches 2025 Rebrand with New Innovative Formulas and Reinforced Commitment to Helping Consumers Perform Better

Premio Mujeres Emprendedoras de la FundacinBayer: Inscripciones abiertas para innovadores en salud y seguridad alimentaria

LEVERKUSEN, Germany, Feb. 4, 2025 /PRNewswire/ -- Bayer Foundation, in partnership with Impact Hub Network, has opened applicationsfor the 2025 Women Entrepreneurs Award, offering 15 winners EUR25,000 and growth support to overcome barriers in scaling innovative solutions for health and food security.

LEVERKUSEN, Germany, Feb. 4, 2025 /PRNewswire/ -- Bayer Foundation, in partnership with Impact Hub Network, has opened applicationsfor the 2025 Women Entrepreneurs Award, offering 15 winners EUR25,000 and growth support to overcome barriers in scaling innovative solutions for health and food security.

LEVERKUSEN, Allemagne, 4 fvrier 2025 /PRNewswire/ -- LaFondation Bayer, en partenariat avec le rseau Impact Hub, a ouvert les candidatures pour le Women Entrepreneurs Award 2025, offrant 15 laurates 25000euros et un soutien la croissance pour surmonter les obstacles l'expansion de solutions innovantes pour la sant et la scurit alimentaire.

LEVERKUSEN, Deutschland, 4. Februar 2025 /PRNewswire/ -- DieBayer Foundation, in Partnerschaft mit Impact Hub Network, nimmt ab sofort Bewerbungenfr den 2025 Women Entrepreneurs Award an. Im Rahmen des Frderprogramms erhalten 15 Gewinnerinnen ein Preisgeld von jeweils 25.000 Euro und Wachstumsuntersttzung, um Hindernisse bei der Skalierung innovativer Lsungen fr Gesundheit und Ernhrungssicherheit zu berwinden.

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment

Patient-centric video training solution builds trust and simplifies clinical trial enrollment, engagement, and retention

DUBAI, UAE, Feb. 4, 2025 /PRNewswire/ -- The inaugural thought-leadership forum by TheDSP Leadership Network - a new business platform for leaders in the healthcare, life sciences, and broader sciences ecosystem - brought together the UAE's brightest minds shaping the future of longevity in the region.

Pilot run to benchmark continuous bioprocessing technology in cultivated meat production. After remarkable results in pharma, Stmm partners with SuperMeat expanding into the food tech industry, facilitated by Varana Capital.

Pilot run to benchmark continuous bioprocessing technology in cultivated meat production. After remarkable results in pharma, Stmm partners with SuperMeat expanding into the food tech industry, facilitated by Varana Capital.

-Wingderm en IMCAS: presentacin de las ltimas innovaciones en depilacin lser y tecnologa de radiofrecuencia

EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex CTDplus multiplex assay. The multiplex assay enables a syndromic approach, simplifying laboratory workflow while delivering fast, actionable results to aid clinicians and laboratorians with the patient diagnosis and management of Systemic Autoimmune Rheumatic Diseases (SARDs).

EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex CTDplus multiplex assay. The multiplex assay enables a syndromic approach, simplifying laboratory workflow while delivering fast, actionable results to aid clinicians and laboratorians with the patient diagnosis and management of Systemic Autoimmune Rheumatic Diseases (SARDs).

- AliveDx ampla su men de enfermedades autoinmunes con el ensayo multiplex MosaiQ AiPlex CTDplus con marcado IVDR-CE para ayudar a diagnosticar enfermedades reumticas autoinmunes sistmicas y agilizar el flujo de trabajo del laboratorio

STOCKHOLM, Feb. 3, 2025 /PRNewswire/ -- Between January 27, 2025, and January 31, 2025,Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

NEW YORK, Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).

CAMBRIDGE, Mass., Feb. 3, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced today that it has entered into a strategic collaboration with Invetx, Inc. ("Invetx"), a Boston-based animal biotechnology company, to develop next-generation animal health biotherapeutics using Nona's HCAb Harbour Mice platform.

MCKINNEY, Texas, Feb. 3, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Fourth Quarter 2024 financial results after the market closes on Wednesday, February 5, 2025. At that time, a copy of the Company's Fourth Quarter 2024 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.